Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 22, 2024

GLP-1 Receptor Agonists and SGLT2 Inhibitors for Treatment of Diabetes in Liver Transplant Recipients

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
Diabetes Obes Metab 2024 Jul 26;[EPub Ahead of Print], K Zheng, A Azhie, X You, M Naghibzadeh, E Tan, S Naimimohasses, VS Sridhar, S Gupta, S Chen, S Dash, C Tsien, N Selzner, L Lilly, E Jaeckel, M Woo, S Singh, D Cherney, M Bhat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading